2025 -
now Founder and Scientific Advisor @ Viamab Therapeutics
2012 -
2026 Professor of Molecular and Cell Biology @
2011 -
2026 Reproductive Biology and Gynaecological Oncology Group Senior Professor @
2008 -
2026 Founding Director of the Centre for NanoHealth @
2018 -
2021 Head of Enterprise and Innovaton @
2020 -
2025 Chair Of The Board Of Trustees @
2015 -
2025 Trustee @
2021 -
2025 Co-vice chair European Technology Platform - Nanomedicine (ETPN) @ European Tecnology Platform - Nanomedicine
2021 -
2024 Advisory Board Member @
Steven Conlan Education
University of London
PhD (Molecular Biology)
1990
-
1994
Swansea University / Prifysgol Abertawe
BSC (Hons) (Biology)
1987
-
1990
Steven Conlan Skills
Laboratory
Clinical Trials
Cell Biology
Chemistry
Lecturing
Confocal Microscopy
Biomedical Engineering
Clinical Research
Biotechnology
Cell
PCR
Healthcare
Cell Culture
Nanomedicine
Scientific Writing
Characterization
Molecular Biology
Lifesciences
Medicine
Entrepreneurship
Oncology
Cancer
Microbiology
Informatics
Research
Genetics
Science
Biochemistry
Technology Transfer
R&D
Molecular
Commercialization
Nanotechnology
Steven Conlan Summary
Steven Conlan, based in Swansea, GB, is currently a Head of the School of Life Sciences at Anglia Ruskin University. Steven Conlan brings experience from previous roles at Viamab Therapeutics and Swansea University. Steven Conlan holds a 1990 - 1994 PhD in Molecular Biology @ University of London. With a robust skill set that includes Laboratory, Clinical Trials, Cell Biology, Chemistry, Lecturing and more. Steven Conlan has 1 emails on RocketReach.
Get contact details of over 700M profiles across 60M companies - all with industry-leading accuracy. Sales and Recruiter users, try out our Email Finder Extension.
Use our AI-Powered Email Finder
Find business and personal emails and mobile phone numbers with exclusive coverage across niche job titles, industries, and more for unparalleled targeting. Also available via our Contact Data API.